PATENT CLAIM ANALYSIS

Application Number: 16143788
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "210000"]

Abstract:
The present invention relates to novel compounds that inhibit Lp-PLA 2  activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA 2 , for example Alzheimer's disease.

Claim (Index 3):
The compound or a pharmaceutically acceptable salt thereof according to  claim 1 , wherein R 1  and R 2  together with the nitrogen and carbon to which they are attached form a 5-membered saturated ring, which ring optionally contains one additional heteroatom ring member selected from N, O and C(O), and R 3  is H.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.32353
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15327706', '14761636', '14234680', '14234687', '14569970']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8272803635514183
- 35 USC 102 Novelty (BERT): 0.5749477938592887
- Combined Prediction Score: 0.8020471065822053
- Mean Citation Score: 381.661348
- Max Citation Score: 451.69055
- Similarity Product: 449.08223690594735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test